Free Trial

Cardinal Health, Inc. (NYSE:CAH) Shares Sold by USS Investment Management Ltd

Cardinal Health logo with Medical background

USS Investment Management Ltd lessened its holdings in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 43.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 33,998 shares of the company's stock after selling 25,780 shares during the quarter. USS Investment Management Ltd's holdings in Cardinal Health were worth $4,022,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Rothschild Investment LLC grew its position in Cardinal Health by 10.1% during the 4th quarter. Rothschild Investment LLC now owns 858 shares of the company's stock worth $101,000 after purchasing an additional 79 shares during the last quarter. Private Trust Co. NA lifted its stake in shares of Cardinal Health by 11.0% during the fourth quarter. Private Trust Co. NA now owns 930 shares of the company's stock worth $110,000 after buying an additional 92 shares during the period. Checchi Capital Advisers LLC grew its holdings in shares of Cardinal Health by 2.7% during the fourth quarter. Checchi Capital Advisers LLC now owns 3,479 shares of the company's stock valued at $411,000 after buying an additional 93 shares during the last quarter. TIAA Trust National Association grew its stake in Cardinal Health by 4.5% during the 4th quarter. TIAA Trust National Association now owns 2,183 shares of the company's stock valued at $258,000 after purchasing an additional 94 shares during the last quarter. Finally, MWA Asset Management grew its stake in Cardinal Health by 2.9% during the 4th quarter. MWA Asset Management now owns 3,324 shares of the company's stock valued at $393,000 after purchasing an additional 95 shares during the last quarter. Institutional investors and hedge funds own 87.17% of the company's stock.

Analyst Upgrades and Downgrades

CAH has been the subject of a number of research reports. Argus set a $148.00 target price on Cardinal Health in a report on Tuesday, February 4th. UBS Group raised their target price on shares of Cardinal Health from $150.00 to $160.00 and gave the stock a "buy" rating in a report on Tuesday, April 29th. Wells Fargo & Company upped their price target on shares of Cardinal Health from $135.00 to $136.00 and gave the company an "equal weight" rating in a report on Tuesday, February 4th. Mizuho increased their price target on Cardinal Health from $142.00 to $150.00 and gave the stock an "outperform" rating in a research report on Monday, March 31st. Finally, Jefferies Financial Group raised Cardinal Health from a "hold" rating to a "buy" rating and boosted their price objective for the company from $140.00 to $150.00 in a report on Wednesday, February 5th. Four research analysts have rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $146.43.

Check Out Our Latest Report on CAH

Cardinal Health Stock Performance

Shares of Cardinal Health stock traded up $1.65 on Tuesday, hitting $154.40. The company's stock had a trading volume of 781,387 shares, compared to its average volume of 2,226,259. The company has a market capitalization of $36.85 billion, a price-to-earnings ratio of 28.80, a price-to-earnings-growth ratio of 1.49 and a beta of 0.66. Cardinal Health, Inc. has a 1 year low of $93.17 and a 1 year high of $156.44. The firm has a fifty day moving average price of $139.99 and a 200-day moving average price of $129.49.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its earnings results on Thursday, May 1st. The company reported $2.35 earnings per share for the quarter, topping the consensus estimate of $2.15 by $0.20. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. The business had revenue of $54.88 billion during the quarter, compared to the consensus estimate of $55.33 billion. During the same period in the prior year, the company posted $2.08 EPS. The business's quarterly revenue was up .0% on a year-over-year basis. As a group, analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be given a $0.5107 dividend. This is a positive change from Cardinal Health's previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Tuesday, July 1st. This represents a $2.04 annualized dividend and a dividend yield of 1.32%. Cardinal Health's dividend payout ratio (DPR) is 31.83%.

About Cardinal Health

(Free Report)

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Read More

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Should You Invest $1,000 in Cardinal Health Right Now?

Before you consider Cardinal Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.

While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns
ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines